USPTO serial 79375221
KIDNEY JACKET
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- AGREDA, SAMANTHA LEIGH
- Law office
- TMO LAW OFFICE 123
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with KIDNEY JACKET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer A. Visintine
Jennifer A. Visintine Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Renal scanning agents for medical use being pharmaceutical preparations for use in ex-vivo and in-vivo diagnosis of kidney disorders; renal scanning agents for medical use being pharmaceutical preparations for use in in-vivo diagnosis of kidney disorders; in-vivo and ex-vivo diagnostic materials for medical use being pharmaceutical preparations for the diagnosis of kidney disorders; diagnostic testing materials for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo diagnostic materials for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo and ex-vivo diagnostic preparations for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; diagnostic preparations for medical use in-vivo diagnosis being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo and ex-vivo radiodiagnostic agents for medical use being pharmaceutical preparations for use in the radiodiagnosis of kidney disorders; diagnostic scanning agents for in-vivo use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in vivo medical diagnostic scanning agents for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; pharmaceutical preparations for the preservation and storage of human organs between transplant surgeries; pharmaceutical preparations for the preservation and storage of human organs; solutions for medical use being pharmaceutical preparations for use in the preservation of organs between transplant surgeries; solutions for medical use being pharmaceutical preparations for use in the storage of organs between transplant surgeries | SECTION 70 - CANCELLED | — |
| 010 | medical supports for the body, namely, a medical sheath for the encasement of donor transplant organs during storage and transportation; medical supports for the body, namely, a medical sheath for the encasement of donor transplant organs during transplantation surgery; surgical apparatus for use in transplant surgery, namely, a medical sheath for the encasement of donor transplant organs during storage and transportation; surgical implants comprised of artificial materials; medical apparatus and instruments for the purposes of long-term graft survival during organ transplant surgery; medical apparatus and instruments for the purposes of short-term graft preservation during organ transplant surgery | SECTION 70 - CANCELLED | — |
| 042 | Research and development of technology in the field of maintenance, preservation, transportation and storage of organs in-vivo and ex-vivo; research and development of new products for others; scientific research to develop new products; scientific research into the development of new products; technical research into the development of new products; medical research services in relation to maintaining and improving the quality of organs in-vivo and ex-vivo; medical and pharmacological research services; medical research, namely, analysis of tissues for medical research; medical and scientific research, namely, conducting clinical trials for others; medical research; scientific research for medical purposes; pharmacological research not for medical purposes, namely, conducting pharmacological testing on organs and body parts in-vivo and ex-vivo; advisory services relating to pharmacology; consultancy pertaining to pharmacology; medical and scientific research, namely, conducting clinical trials for others; providing information about medical and scientific research in the field of pharmaceuticals, clinical trials and organ transplant surgeries; providing scientific research information and information about new product design, including online; scientific research consultancy in the field of pharmaceuticals, clinical trials and organ transplant surgeries; scientific research | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 28, 2026 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| May 28, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 19, 2026 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 5, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 5, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 5, 2025 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 5, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 10, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 25, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 25, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 21, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 19, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 17, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 15, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 15, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 15, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 6, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 18, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 18, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 30, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 29, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 15, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 10, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 27, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |